Case Report
Clinical remission of Crohn’s disease symptoms following the adoption of therapeutic carbohydrate reduction: A retrospective single case report
Submitted: 16 October 2025 | Published: 18 March 2026
About the author(s)
Henry M. Walker, Kaiser Foundation Hospital, Los Angeles, California, United StatesMelanie M. Tidman, Doctor of Health Science, Liberty University, Lynchburg, Virginia, United States of America; and Doctor of Health Science, A.T. Still University, Mesa, Arizona, United States of America; and Department of Occupational Therapy, Nova Southeastern University, Ft. Lauderdale, Florida, United States
Dawn R. White, School of Health Professional, National University, San Diego, California, United States of America; and Glaser Center for Grounded Theory, Institute for Research and Theory Methodology, Poway, California, United States of America; and Benerd College, University of Pacific, Stockton, California, United States
Timothy A. White, School of Health Sciences, American Public University Systems, Charles Town, West Virginia, United States of America; and Department of Global Health Services and Administration, University of Maryland Global Campus, Adelphi, New York; and Glaser Center for Grounded Theory, Institute for Research and Theory Methodologies, Poway, California, United States
Abstract
Low-carbohydrate dietary approaches are increasingly explored as adjunctive strategies for Crohn’s disease (CD), particularly in patients who experience limitations or adverse effects with standard biologic therapies. Dietary intervention (DI) may offer a non-pharmacological option to support symptom control and remission. Evidence remains limited, particularly at the individual clinical level. This single-patient, retrospective case report describes an adult with established CD who initiated a therapeutic carbohydrate-restricted diet under clinical guidance. The intervention was implemented as part of ongoing disease management and followed longitudinally during routine care. Clinical outcomes were assessed through symptom patterns, medication use, and sustained follow-up over an extended observation period. Following initiation of the carbohydrate-restricted dietary approach, the patient achieved remission of gastrointestinal symptoms and progressively discontinued pharmacologic therapy. Symptom recurrence was temporally associated with lapses in dietary adherence and resolved promptly upon resumption of the intervention. Sustained adherence was related to continued symptom control and medication independence throughout follow-up. This case suggests that therapeutic carbohydrate reduction may support remission and medication discontinuation in select individuals with CD. The findings underscore the need for controlled clinical trials to evaluate the safety, durability and generalisability of DIs in inflammatory bowel disease. Dietary strategies may represent a complementary avenue for individualised disease management.
Keywords
Metrics
Total abstract views: 659Total article views: 666
